Euro-Med Laboratories Phil., Inc. Stock price

Equities

EURO

PHY2352T1098

Pharmaceuticals

End-of-day quote Philippines S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
0.79 PHP 0.00% Intraday chart for Euro-Med Laboratories Phil., Inc. +8.22% +5.33%
Sales 2021 3.59B 63.82M Sales 2022 4.22B 75.15M Capitalization 3.58B 63.65M
Net income 2021 169M 3.01M Net income 2022 200M 3.56M EV / Sales 2021 2.36 x
Net Debt 2021 2.69B 47.91M Net Debt 2022 2.87B 51.14M EV / Sales 2022 1.53 x
P/E ratio 2021
34.1 x
P/E ratio 2022
17.9 x
Employees 1,551
Yield 2021
1.43%
Yield 2022
4.02%
Free-Float 11.69%
More Fundamentals * Assessed data
Dynamic Chart
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 27 November 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Euro-Med Laboratories Phil., Inc. Approves Cash Dividend, Payable on 21 November 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Euro-Med Laboratories Phil., Inc. Approves Declaration of Cash Dividend as of 31 December 2020, Paid on 24 January 2022 CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Euro-Med Laboratories Phil., Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
Euro-Med Laboratories Phil., Inc. Appoints Mr. Anthony Joseph Y. Gaw as Director CI
Euro-Med Laboratories Phil., Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
More news
1 week+8.22%
3 months+5.33%
6 months-4.82%
Current year+5.33%
More quotes
1 week
0.72
Extreme 0.72
0.79
1 month
0.72
Extreme 0.72
0.79
Current year
0.71
Extreme 0.71
0.80
1 year
0.70
Extreme 0.7
0.89
3 years
0.70
Extreme 0.7
2.33
5 years
0.70
Extreme 0.7
4.49
10 years
0.70
Extreme 0.7
4.49
More quotes
Managers TitleAgeSince
President 63 89-12-31
Compliance Officer 73 06-12-31
Director/Board Member 69 89-12-31
Members of the board TitleAgeSince
Director/Board Member 52 92-12-31
Director/Board Member 75 14-06-17
Chairman 77 89-12-31
More insiders
Date Price Change Volume
24-03-27 0.79 0.00% 2,000
24-03-26 0.79 +6.76% 16,000
24-03-25 0.74 0.00% 4,000
24-03-22 0.74 +1.37% 1,000
24-03-21 0.73 0.00% 5,000

End-of-day quote Philippines S.E., March 26, 2024

More quotes
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.
More about the company
  1. Stock
  2. Equities
  3. Stock Euro-Med Laboratories Phil., Inc. - Philippines S.E.